Asia shares dip as tariffs weigh on EU and US growth
The initial relief over Europe's 15% levy quickly soured when set against the 1% to 2% that stood before President Donald Trump took office. Leaders in France and Germany lamented the outcome as a drag on growth, pulling down stocks and bond yields across the continent while slugging the single currency.
Trump also flagged a 'world tariff' rate of 15% to 20% on all trading partners that were not negotiating a deal, among the highest rates since the Great Depression of the 1930s.
'While the worst case scenario was averted, the implied EU tariff increase from 1% in January is a significant tax increase on EU exports,' wrote economists from JPMorgan in a note.
'This is a very big shock that unwinds a century of U.S. leadership in global free trade,' they warned. 'While we no longer see a U.S. recession as our baseline from this shock, the risk is still elevated at 40%.'
A further risk to world growth came from a sudden spike in oil prices after Trump threatened a new deadline of 10 or 12 days for Russia to make progress toward ending the war in Ukraine or face tougher sanctions on oil exports.
Brent edged up 0.1% to $70.10 a barrel, having climbed 2.3% on Monday, while U.S. crude held at $66.73.
The air of caution saw MSCI's broadest index of Asia-Pacific shares outside Japan slip 0.7%. Japan's Nikkei eased 0.8%, while Chinese blue chips fell 0.1%.
European shares steadied after Monday's sell-off. EUROSTOXX 50 futures edged up 0.2%, while FTSE futures and DAX futures both added 0.1%.
The euro was flat at $1.1592, after falling 1.3% overnight in the largest drop since mid-May. It now has chart support at $1.1556.
The dollar index was up at 98.674, after the rush out of short dollar positions lifted it 1% overnight, while it touched a one-week high on the yen at 148.63.
Wall Street held firm on hopes for upbeat results from mega caps this week that include Apple, Microsoft and Amazon.
S&P 500 futures nudged up 0.1%, while Nasdaq futures added 0.2%.
Yields on 10-year Treasuries held at 4.408% having crept higher on Monday as markets braced for another steady decision on interest rates from the Federal Reserve.
Futures imply a 97% chance the Fed will keep rates at 4.25%-4.5% at its meeting on Wednesday and reiterate concerns that tariffs will push inflation higher in the short term.
Analysts also assume one, or maybe two, Fed officials will dissent in favour of a cut and supporting wagers for a move in September.
The odds could change depending on a slew of U.S. data this week including gross domestic product for the second quarter where growth is seen rebounding to an annualised 2.4%, after a 0.5% contraction in the first quarter.
Figures on job openings are due later on Tuesday that will help refine forecasts for the crucial payrolls report on Friday.
Canada's central bank also meets on Wednesday and again is widely expected to hold rates at 2.75% as it waits to see how trade talks with the U.S. wash out.
In commodity markets, prices for copper and iron ore were under pressure while gold idled at $3,316 an ounce. - Reuters
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Sun
an hour ago
- The Sun
Lee Kum Kee Supports the 2025 Asian Championship of World Chinese Cuisine
HONG KONG, CHINA - Media OutReach Newswire - 29 July 2025 - The 2025 Asian Championship of World Chinese Cuisine, organised by the World Federation of Chinese Catering Industry, was held on 26th June 2025 at the Chinese Culinary Institute in Hong Kong, China. As the title sponsor, Lee Kum Kee provided contestants with its sauce products for use, empowering top chefs from across Asia in crafting exquisite dishes and compete for top honours. This marks the first time the competition being hosted in Hong Kong, China, drawing 70 teams of Chinese cuisine chefs from across Asia to showcase their culinary skills and foster expertise exchange. Each team was tasked with preparing one cold dish and two hot dishes within 90 minutes. A panel of professional judges evaluated the entries based on taste, creativity, presentation, and execution. Throughout the competition, the chefs tactfully incorporated a variety of Lee Kum Kee sauces into their creations, demonstrating the versatile applications of the brand's sauce products in professional settings. The event also served as a valuable platform for chefs to connect, exchange ideas, and elevate their culinary craftsmanship. Following the one-day intense battle, the results were revealed at the 'Lee Kum Kee Gala Dinner – 2025 Asian Championship of World Chinese Cuisine Awarding Ceremony'. The night brought together contestants, industry representatives and guests throughout Asia to enjoy a specially curated banquet featuring dishes made with Lee Kum Kee sauces and celebrate the achievements of winning chefs. Dodie Hung, Executive Vice President – Corporate Affairs of Lee Kum Kee said, 'Lee Kum Kee has always been working closely with culinary partners and chefs in supporting various cooking competitions and industry symposiums. We are thrilled to see chefs from across the region using our sauce products to curate delicious and innovative dishes in this prestigious competition. We look forward to continuing our collaboration with chefs to deliver superior Asian culinary experiences and promote Chinese culinary culture worldwide.'
Free Malaysia Today
2 hours ago
- Free Malaysia Today
Rating firms say US tariffs alone will not trigger EU sovereign downgrades
At a sector level, Moody's warned that 'the credit effects will be significant' for companies that export a lot to the US. (EPA Images pic) LONDON : The sharp increase in US trade tariffs on the EU will not trigger immediate sovereign rating cuts, but could compound existing pressures, Fitch and other agencies said today, while Moody's warned of the effect on exporting firms. One of Fitch's top sovereign analysts, Ed Parker, said the US' baseline tariff of 15% on imports from the EU was in line with assumptions the rating agency has had since March and therefore did not materially shift its economic forecasts. 'Nevertheless, the 15% rate is a huge increase relative to the 1.2% rate of last year,' he said. 'We don't expect the increase in the tariff rate to directly drive EU rating changes on its own, but it could compound existing credit pressures,' Parker told Reuters. Smaller European-based agency Scope Ratings and Morningstar DBRS echoed the view, with Scope's head of sovereign ratings, Alvise Lennkh-Yunus, saying the tariffs arrived 'against a backdrop of accumulating economic shocks'. At a sector level, Moody's warned that 'the credit effects will be significant' for companies that export a lot to the US, depend on complex global supply chains and have limited pricing power in their markets. That includes carmakers like Stellantis and Volkswagen, whose ratings Moody's recently downgraded. Large diversified European manufacturing companies like Siemens and ABB generate about 25% of their revenue in the US. However, they tend to follow local-for-local strategies, sourcing at least 80% of their procurement within the US and should be able to pass at least some of the tariff increases on to customers. Uncertainty still remains about key goods such as semiconductors and pharmaceuticals. The pharmaceutical sector amounts to 25% of all EU exports to the US, analysts estimate. The exemption of aircraft components meanwhile eases expected tariff-related pressures for Airbus and MTU Aero Engines, 'which reinforces our already positive outlook for the global aerospace and defence sector,' Moody's said. It also said the 15% rate had been broadly in line with expectations it laid out when it cut its euro zone economic growth forecast for the year to below 1% in May. It did not give an EU-wide sovereign view, although it said Ireland, which it rates at Aa3 and has a 'positive' outlook on, was most exposed with total value-added exports to the US accounting for around 8% of its GDP back in 2020.
Free Malaysia Today
2 hours ago
- Free Malaysia Today
Philips chops back US tariff bill
Shares in Philips jumped more than 10% during morning trading. (EPA Images pic) AMSTERDAM : Dutch medical equipment manufacturer Philips said today that the impact of US tariffs would be much less than it initially estimated, sending its share price surging. The company had originally estimated in April that US tariffs could cost it €250 million to €300 million this year after President Donald Trump unveiled a 20% tariff rate for goods from the EU. Brussels and Washington reached a deal over the weekend that will see goods from the EU face a baseline 15% levy when imported into the US. It said today it now expects between €150 million and €200 million impact from US tariffs this year. Chief executive Roy Jakobs said Philips updated 'the guidance because we have certainty now around what is happening between the EU and the US.' Shares in Philips jumped more than 10% during morning trading, while the Amsterdam market rose around 0.4% overall. The trade deal has come under widespread criticism in Europe as having been lopsided, saddling its manufacturers with a costly 15% rate with little in return from the US as certainty is a relative concept given Trump's propensity to change positions. Jakobs said that certainty 'is what we value in' in the deal, while acknowledging 'it's a painful additional cost we have to carry'. The company still targets a one to 3% increase in annual sales. Second quarter net profit fell by 47% to €240 million, but last year's performance was boosted by exceptional income from insurance payouts linked to long-running issues with its sleep apnoea machines. Sales slid by 2.8% to €4.3 billion, although they edged higher on a comparable basis that excludes currency changes. The company also noted orders rose by 6% on a comparable basis. The appreciation of the euro relative to the dollar and other currencies has been crimping the results of European companies as their revenues abroad result in fewer euros on the balance sheet. Long known for its light bulbs and television sets, the Dutch company has refocused its business towards medical equipment.
